Home LiteratureArticle Details
PMID: 1327751 Published · ppublish English Journal Article

Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens.

The EMBO journal ·Vol. 11 ·No. 11 ·1992-11-00 ·Pages 3935-40

Crook T, Vousden KH

Abstract

Primary human papillomavirus (HPV) positive anogenital cancers normally develop without somatic mutation within the p53 gene. In this study, however, we have identified p53 point mutations in metastases arising from HPV positive cervical carcinomas, suggesting that acquisition of p53 mutation may play a role in the progression of some HPV associated primary cancers. p53 mutants identified in anogenital cancers exhibit a dominant transforming phenotype and increased resistance to HPV16 E6 directed degradation. The association of p53 mutation with metastases may explain the poor prognosis reported for HPV negative primary cancers, many of which already contain mutant p53. A high proportion of p53 mutations detected in both primary and metastatic cancers are GC-->TA transversions, strongly suggesting a role for external carcinogens in the development of these cancers.

Related Genes
MeSH Terms
Animals Cell Line Codon/genetics Exons Female Genes, Viral Genes, p53 Humans Mutation Neoplasm Metastasis/genetics Neoplasm Staging Oncogene Proteins, Viral/genetics Papillomaviridae/genetics,isolation & purification Plasmids Polymerase Chain Reaction/methods Protein-Tyrosine Kinases/genetics Rats Repressor Proteins Suppression, Genetic Uterine Cervical Neoplasms/genetics,microbiology,pathology,secondary
Chemicals
Codon E6 protein, Human papillomavirus type 16 Oncogene Proteins, Viral Repressor Proteins Protein-Tyrosine Kinases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Crook T
Ludwig Institute for Cancer Research, St Mary's Hospital Medical School, London, UK.
Vousden K H
References (41)
41 references, click to expand
  1. Carcinogens leave fingerprints.
    Nature. 1992 Jan 16;355(6357):209-10 PMID: 1309937
  2. Clonal expansion of p53 mutant cells is associated with brain tumour progression.
    Nature. 1992 Feb 27;355(6363):846-7 PMID: 1311419
  3. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.
    EMBO J. 1992 Apr;11(4):1383-90 PMID: 1314165
  4. TP53 tumor suppressor gene: a model for investigating human mutagenesis.
    Genes Chromosomes Cancer. 1992 Jan;4(1):1-15 PMID: 1377002
  5. Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus.
    Oncogene. 1991 Jul;6(7):1251-7 PMID: 1650445
  6. Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.
    Cancer Res. 1991 Oct 1;51(19):5232-7 PMID: 1717142
  7. Temperature-sensitive mutants of p53 associated with human carcinoma of the lung.
    Oncogene. 1992 Jan;7(1):71-6 PMID: 1741167
  8. Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype.
    Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):570-4 PMID: 1846447
  9. p53 mutations in human cancers.
    Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
  10. p53 is frequently mutated in Burkitt's lymphoma cell lines.
    EMBO J. 1991 Oct;10(10):2879-87 PMID: 1915267
  11. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
    Science. 1990 Nov 30;250(4985):1233-8 PMID: 1978757
  12. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.
    EMBO J. 1990 Jan;9(1):153-60 PMID: 2153075
  13. A genetic model for colorectal tumorigenesis.
    Cell. 1990 Jun 1;61(5):759-67 PMID: 2188735
  14. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.
    Nature. 1990 Dec 20-27;348(6303):747-9 PMID: 2259385
  15. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.
    Eur J Biochem. 1986 Sep 15;159(3):529-34 PMID: 2428616
  16. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.
    J Virol. 1989 Oct;63(10):4417-21 PMID: 2476573
  17. Mutations in the p53 gene occur in diverse human tumour types.
    Nature. 1989 Dec 7;342(6250):705-8 PMID: 2531845
  18. Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras.
    EMBO J. 1989 Feb;8(2):513-9 PMID: 2542020
  19. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.
    EMBO J. 1989 Dec 20;8(13):4099-105 PMID: 2556261
  20. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
    J Virol. 1989 Feb;63(2):739-46 PMID: 2642977
  21. Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients.
    J Exp Med. 1988 Apr 1;167(4):1442-58 PMID: 3128633
  22. Mutagenic mucus in the cervix of smokers.
    J Natl Cancer Inst. 1986 Jun;76(6):983-6 PMID: 3458964
  23. Overproduction of p53 antigen makes established cells highly tumorigenic.
    Nature. 1985 Jul 11-17;316(6024):158-60 PMID: 3892307
  24. Isolation of a transforming sequence from a human bladder carcinoma cell line.
    Cell. 1982 May;29(1):161-9 PMID: 6286138
  25. Molecular basis of base substitution hotspots in Escherichia coli.
    Nature. 1978 Aug 24;274(5673):775-80 PMID: 355893
  26. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours.
    Lancet. 1992 May 2;339(8801):1070-3 PMID: 1349102
  27. p53 point mutation in HPV negative human cervical carcinoma cell lines.
    Oncogene. 1991 May;6(5):873-5 PMID: 1646990
  28. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.
    Cell. 1991 Nov 1;67(3):547-56 PMID: 1657399
  29. Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells.
    Am J Pathol. 1991 Jan;138(1):1-8 PMID: 1846261
  30. Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product.
    J Virol. 1991 Sep;65(9):4966-72 PMID: 1870208
  31. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA.
    Lancet. 1990 May 19;335(8699):1171-4 PMID: 1971033
  32. Structural aspects of the p53 protein in relation to gene evolution.
    Oncogene. 1990 Jul;5(7):945-52 PMID: 2142762
  33. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
    Cell. 1990 Dec 21;63(6):1129-36 PMID: 2175676
  34. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
    Cell Growth Differ. 1990 Dec;1(12):571-80 PMID: 2288874
  35. Comparison of the in vitro transforming activities of human papillomavirus types.
    EMBO J. 1988 Jun;7(6):1815-20 PMID: 2458921
  36. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases?
    Int J Cancer. 1989 Jan 15;43(1):41-4 PMID: 2536006
  37. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.
    EMBO J. 1989 Dec 1;8(12):3905-10 PMID: 2555178
  38. Human papillomaviruses and cervical carcinoma.
    Cancer Cells. 1989 Oct;1(2):43-50 PMID: 2561870
  39. p53 increases experimental metastatic capacity of murine carcinoma cells.
    Mol Cell Biol. 1988 May;8(5):2078-81 PMID: 3290647
  40. Primary structure polymorphism at amino acid residue 72 of human p53.
    Mol Cell Biol. 1987 Feb;7(2):961-3 PMID: 3547088
  41. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
    J Mol Appl Genet. 1982;1(4):327-41 PMID: 6286831
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1992-11-00
Pages
3935-40
Language
English
Region
England
NLM ID
8208664
PMCID
PMC556904
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com